Dr. Eric Teller earned his BA, Summa cum Laude, from Yeshiva University and his medical degree from Robert Wood Johnson Medical School - University of Medicine of New Jersey in 2002. He was trained in Internal Medicine at Robert Wood Johnson University Hospital in New Brunswick, New Jersey between 2002 and 2005. After a year as Chief Resident in Internal Medicine, he completed a fellowship in pulmonary, critical care and sleep medicine at New York Presbyterian Hospital - Columbia University Medical Center.
Dr. Teller joined Kamelhar Pulmonary in 2009. He has a faculty appointment at NYU School of Medicine where he teaches medical students, residents and fellows at NYU Langone Medical Center. He performs bronchoscopies at the hospital to diagnose patients with lung cancer, infections and other lung diseases. Dr. Teller was awarded a grant during fellowship from the ResMed Foundation for the treatment of sleep disordered breathing in patients with congestive heart failure. He specializes in the diagnosis and management of the breathing and sleep problems in patients with heart disease. He has privileges at New York Eye and Ear Infirmary where he interprets sleep studies. His expertise includes sleep apnea, insomnia, other sleep disorders, cough, asthma, chronic obstructive lung disease, sinus disease, lung cancer and interstitial lung disease. Dr. Teller prides himself on using an evidence based approach in the treatment of patients. He customizes the plan for each patient and utilizes relationships with other specialists, therapists and DME companies throughout NYC and beyond to find the right approach in the management of each patient’s underlying disease.
Morganstein N, Doyle-Lindrud S, Goodin S, Shih J, Altscher A, Zager R, Todd M, Durivage H, Teller E, Dipaola R S. “A Phase II Salvage Trial of Transdermal estradiol in the Treatment of Hormone and Chemotherapy Refractory Prostate Cancer.” Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), Vol. 22, No. 14S (July 15 Supplement), 2004, page 4695.
Elsayed Y A, Altscher A, Hillard B, Doyle-Lindrud S, Goodin S, Shih W J, Rubin, E H, Teller E, Dipaola R S. “A Phase I/II Trial of 13-Cis Retinoic Acid, Alpha Interferon, Docetaxel, and Estramustine (R.I.T.E.) for the Treatment of Hormone Refractory Prostate Cancer (HRPC).” Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), Vol. 22, No. 14S (July 15 Supplement), 2004, page 4707.
Birshtein B K, Teller E. “Designing a Construct to Knockout the Immunoglobulin HS4 Enhancer.” Sigma Delta Rho Science Research Honors Society – Abstract and Poster Session, 1997, pp. 32-33.
Teller E. “The Changing Face Of Medicine.” Yeshiva University Medical Journal, December 1995, Vol.1, No.2, pp.13-15.
Teller E. “Critical Care.” Nefesh: Undergraduate Health Perspectives, May 1996, Vol. 2, No. 1, pp. 14-16.